tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Ownership - Who Owns SAB Biotherapeutics?

Compare
313 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2025
xxxxxxxxxxxxx
$3004005
Dec 31, 2025
xxxxxxxxxxxxx
$8017007

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,232,304Insider10.99%19,830,432
4,401,500Institution9.25%16,681,685
2,857,142Insider6.00%10,828,568
2,850,881Institution5.99%10,804,839
2,198,457Insider4.62%8,332,152
2,198,457Insider4.62%8,332,152
2,143,585Institution4.50%8,124,187
1,717,280Institution3.61%6,508,491
803,210Institution1.69%3,044,166
766,699Insider1.61%2,905,789

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
304,080Institution0.64%1,152,463
70,783Institution0.15%268,268
3,669Institution<0.01%13,906

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,640,793Institution3.45%7,203,081
208,227Institution0.44%743,370
76,487Institution0.16%335,778
24,998Institution0.05%94,742

FAQ

Who Owns SAB Biotherapeutics (SABS)?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by institutional investors?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of SAB Biotherapeutics (SABS)?
Eddie Joe Sullivan owns the most shares of SAB Biotherapeutics (SABS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.